Chloe I Bloom1, Courtney Franklin2, Andrew Bush3, Sejal Saglani3, Jennifer K Quint3. 1. National Heart and Lung Institute, Imperial College London, London, United Kingdom. Electronic address: chloe.bloom06@imperial.ac.uk. 2. London School of Hygiene and Tropical Medicine, London, United Kingdom. 3. National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Abstract
BACKGROUND: Wheeze is one of the most common symptoms of preschool children (age 1-5 years), yet we have little understanding of the burden in the United Kingdom. OBJECTIVES: We sought to determine prevalence and pattern of physician-confirmed preschool wheeze, related health care utilization, and factors associated with progression to school-age asthma. METHODS: We used nationally representative primary and secondary care electronic medical records between 2007 and 2017 to identify preschool children with wheeze. Factors associated with asthma progression were identified in a nested cohort of children with follow-up from age 1 to 2 years, until at least age 8 years. RESULTS: From 1,021,624 preschool children, 69,261 were identified with wheeze. Prevalence of preschool wheeze was 7.7% in 2017. Wheeze events were lowest in August and highest in late-autumn/early-winter. During median follow-up of 2 years (interquartile range, 1.2-4.0 years), 15.8% attended an emergency department, and 13.9% had a hospital admission, for a respiratory disorder. The nested cohort with prolonged follow-up identified 15,085 children; 35.5% progressed to asthma between age 5 and 8 years. Of children with preschool wheeze, without an asthma diagnosis, 34.9% were prescribed inhaled corticosteroids and 15.6% oral corticosteroids. The factors most strongly associated with progression to asthma were wheeze frequency and severity, atopy, prematurity, maternal asthma severity, and first reported wheeze event occurring in September. CONCLUSIONS: Preschool wheeze causes considerable health care burden, and a large number of children are prescribed asthma medication and have unplanned secondary care visits. Multiple factors influence progression to asthma, including first wheeze event occurring in September.
BACKGROUND: Wheeze is one of the most common symptoms of preschool children (age 1-5 years), yet we have little understanding of the burden in the United Kingdom. OBJECTIVES: We sought to determine prevalence and pattern of physician-confirmed preschool wheeze, related health care utilization, and factors associated with progression to school-age asthma. METHODS: We used nationally representative primary and secondary care electronic medical records between 2007 and 2017 to identify preschool children with wheeze. Factors associated with asthma progression were identified in a nested cohort of children with follow-up from age 1 to 2 years, until at least age 8 years. RESULTS: From 1,021,624 preschool children, 69,261 were identified with wheeze. Prevalence of preschool wheeze was 7.7% in 2017. Wheeze events were lowest in August and highest in late-autumn/early-winter. During median follow-up of 2 years (interquartile range, 1.2-4.0 years), 15.8% attended an emergency department, and 13.9% had a hospital admission, for a respiratory disorder. The nested cohort with prolonged follow-up identified 15,085 children; 35.5% progressed to asthma between age 5 and 8 years. Of children with preschool wheeze, without an asthma diagnosis, 34.9% were prescribed inhaled corticosteroids and 15.6% oral corticosteroids. The factors most strongly associated with progression to asthma were wheeze frequency and severity, atopy, prematurity, maternal asthma severity, and first reported wheeze event occurring in September. CONCLUSIONS: Preschool wheeze causes considerable health care burden, and a large number of children are prescribed asthma medication and have unplanned secondary care visits. Multiple factors influence progression to asthma, including first wheeze event occurring in September.
Authors: Young J Juhn; Euijung Ryu; Chung-Il Wi; Katherine S King; Momin Malik; Santiago Romero-Brufau; Chunhua Weng; Sunghwan Sohn; Richard R Sharp; John D Halamka Journal: J Am Med Inform Assoc Date: 2022-06-14 Impact factor: 7.942
Authors: Anastasia Filiou; Idun Holmdahl; Anna Asarnoj; Marianne van Hage; Tina Ekenkrantz; Niclas Rydell; Anders Sjölander; Katarina Stenberg-Hammar; Gunilla Hedlin; Jon R Konradsen; Cilla Söderhäll Journal: Int Arch Allergy Immunol Date: 2022-01-18 Impact factor: 3.767
Authors: Segundo Rite; Carlos Martín de Vicente; Juan P García-Iñiguez; María L Couce; María P Samper; Alicia Montaner; Carmen Ruiz de la Cuesta Journal: Front Pediatr Date: 2022-02-04 Impact factor: 3.418
Authors: Hanna Creese; Eric Lai; Kate Mason; Daniela K Schlüter; Sejal Saglani; David Taylor-Robinson; Sonia Saxena Journal: Thorax Date: 2021-10-14 Impact factor: 9.102